IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Quality of Life Among Children and Adolescents With Cancer
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2005 by Children's Mercy Hospital Kansas City.
Recruitment status was: Active, not recruiting
Recruitment status was: Active, not recruiting
Sponsor:
Children's Mercy Hospital Kansas City
Information provided by:
Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier:
NCT00285363
First received: January 31, 2006
Last updated: NA
Last verified: March 2005
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This descriptive study aims to allow children and adolescents who have cancer to self-evaluate their quality of life. It is hypothesized that treatment affects quality of life in the areas of physical and social functioning. It is further hypothesized that these effects dissipate within 6 months after treatment is completed.
| Condition |
|---|
| Cancer |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional Time Perspective: Retrospective/Prospective |
| Official Title: | Quality of Life Among Children and Adolescents With Cancer |
Further study details as provided by Children's Mercy Hospital Kansas City:
| Estimated Enrollment: | 75 |
| Study Start Date: | March 2005 |
| Estimated Study Completion Date: | March 2005 |
Study participants will include all children and adolescents (aged 7 to 21 years old) currently receiving care from the Hematology/Oncology Clinic at the CMHC, which will serve as the study site. These individuals will be identified by the health care professionals working in the clinic. Specific study criteria will include only those individuals who (1) can read or write in the English language (due to limited availability of translators); (2) appear to not possibly suffer psychological harm by participating (as determined by any health care professional working in the Clinic); and (3) do not have a health condition and/or medical need that supersedes study participation. The weekly list of appointments will be reviewed by the researchers who already work in the Clinic for appropriateness (JH, JB and KS). To prevent participation coercion, solicitation for participation will be provided through the Child Life Specialist (CLS). The CLS is known to each participant and will function as a data collector for this study.
Eligibility| Ages Eligible for Study: | 9 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:Study participants will include all children and adolescents (aged 7 to 21 years old) currently receiving care from the Hematology/Oncology Clinic at the CMHC, which will serve as the study site. These individuals will be identified by the health care professionals working in the clinic. Specific study criteria will include only those individuals who (1) can read or write in the English language (due to limited availability of translators); (2) appear to not possibly suffer psychological harm by participating (as determined by any health care professional working in the Clinic); and (3) do not have a health condition and/or medical need that supersedes study participation. -
Exclusion Criteria: (1) Those electing not to participate; (2) those with no guardian available to consent or (3) those not yet diagnosed with a cancer condition.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00285363
Please refer to this study by its ClinicalTrials.gov identifier: NCT00285363
Locations
| United States, Missouri | |
| Children's Mercy Hospitals and Clinics | |
| Kansas City, Missouri, United States, 64108 | |
Sponsors and Collaborators
Children's Mercy Hospital Kansas City
Investigators
| Principal Investigator: | Peggy Ward-Smith, PhD | University of Missouri, Kansas City |
More Information
| ClinicalTrials.gov Identifier: | NCT00285363 History of Changes |
| Other Study ID Numbers: |
04 05-052E CMCC grant |
| Study First Received: | January 31, 2006 |
| Last Updated: | January 31, 2006 |
Keywords provided by Children's Mercy Hospital Kansas City:
|
cancer quality of life adolescents |
ClinicalTrials.gov processed this record on September 21, 2017